Ring-opening polymerization of ε-caprolactone initiated by the antitumor agent doxifluridine

Acta Biomaterialia

Volumn 5, Issue 4, 2009, Pages 1075-1081

  Chang, Kuo Yung ^a   Lee, Yu Der ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

5 Deoxy 5 fluorouridine; Antitumor agent; Drug delivery; Poly( caprolactone); Ring open polymerization

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; GEL PERMEATION CHROMATOGRAPHY; GRAFTING (CHEMICAL); RING OPENING POLYMERIZATION; TARGETED DRUG DELIVERY; TIN COMPOUNDS;

5′-DEOXY-5-FLUOROURIDINE; ANTITUMOUR AGENTS; DOXIFLURIDINE; POLY(Ε CAPROLACTONE); POLY(Ε-CAPROLACTONE); PROTON NUCLEAR MAGNETIC RESONANCE; RING OPEN POLYMERIZATION; SYNTHESISED; ]+ CATALYST; Ε-CAPROLACTONE;

MOLECULAR WEIGHT;

ANTINEOPLASTIC AGENT; DOXIFLURIDINE; DOXIFLURIDINE POLYCAPROLACTONE; POLYCAPROLACTONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR WEIGHT; POLYMERIZATION; PRIORITY JOURNAL; RING OPENING;

EID: 64449086428     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2008.11.010     Document Type: Article

References (47)

1. Ulbrich K., and Šubr V. Polymeric anticancer drugs with pH-controlled activation. Adv Drug Deliv Rev 56 (2004) 1023-1050
2. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6 (2006) 688-701
3. Duncan R. Drug-polymer conjugates: potential for improved chemotherapy. Anticancer Drugs 3 (1992) 175-210
4. Pechar M., Ulbrich K., and Subr V. Poly(ethylene glycol) multi-block copolymer as a carrier of the anti-cancer drug doxorubicin. Bioconjugate Chem 11 (2000) 131-139
5. Vicent M.J., Manzanaro S., Fuente J.A.D.L.d.l., and Duncan R. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics. J Drug Target 12 8 (2004) 503-515
6. Říhová B., Etrych T., Pechar M., Jelínková M., Štastný M., Hovorka O., et al. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. J Control Release 74 (2001) 225-232
7. Kovář M., Mrkvana T., Strohalmb J., Etrychb T., Ulbrichb K., Štastný M., et al. HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia. J Control Release 92 (2003) 315-330
8. Etrych T., Jelínková M., Říhová B., and Ulbrich K. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. J Control Release 73 (2001) 89-102
9. Hoste K., Schach E., and Seymour L. New derivatives of polyglutamic acid as drug carrier systems. J Control Release 64 (2000) 53-61
10. Singer J.W., Baker B., de Vries P., Kumar A., Shaffer S., and Vawter E. Poly-(l)-glutamic acid-paclitaxel, a biodegradable polymeric drug conjugate. Adv Exp Med Biol 519 (2003) 81-99
11. Li C. Poly(l-glutamic acid)-anticancer drug conjugates. Adv Drug Deliv Rev 54 (2002) 695-713
12. Greenwald R.B., Choe Y.H., McGuire J., and Conover C.D. Effective drug delivery by PEGylated drug conjugates. Adv Drug Del Rev 55 (2003) 217-250
13. Mitra S., Gaur U., Ghosh P.C., and Maitra A.N. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74 (2001) 317-323
14. Wang Y.S., Liu L.R., Jiang Q., and Zhang Q.Q. Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin. Eur Polym J 43 (2007) 43-51
15. Heidelberger C. In: Holland J.F. (Ed). Cancer medicine (1993), Lea and Febiger, Philadelphia, PA 801-819
16. Miwa M., Ura M., Nishida M., Sawada N., Ishikawa T., Mori K., et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34 (1998) 1274-1281
17. Connolly K.M., Diasio R.B., Armstrong R.D., and Kaplan A.M. Decreased immunosuppression associated with anticancer activity of 5′-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine. Cancer Res 43 (1983) 2529-2535
18. Niitani H., Kimura K., Saito T., Nakao I., Abe O., Urushizaki I., et al. Phase II combination study of 5′-deoxy-5-fluorouridine (5′-DFUR) on patients with malignant cancer: multi-institutional cooperative study. Jpn J Cancer Chemother 12 (1985) 2044-2051
19. Kimura K., Saito T., and Tagki T. Experimental and clinical studies on the anticancer agent doxifluridine (5-dFUR). J Int Med Res 16 (1988) 1B-37B
20. Ota K. Multicentre cooperative phase II study of 5-deoxy-5- fluorouridine in the treatment of colorectal adenocarcinoma. J Int Med Res 16 (1988) 19B-20B
21. Dong C.M., Guo Y.Z., Qiu K.Y., Gu Z.W., and Feng X.D. In vitro degradation, controlled release behavior of d,l-PLGA50 and PCL-b-d,l-PLGA50 copolymer microspheres. J Control Release 107 (2005) 53-64
22. Peña J., Corrales T., Izquierdo-Barba I., Serrano M.C., Portolés M.T., Pagani R., et al. Alkaline-treated poly(ε-caprolactone) films: degradation in the presence or absence of fibroblasts. J Biomed Mater Res 76A (2006) 788-797
23. Bei J.Z., Li J.M., Wang Z.F., Le J.C., and Wang S.G. Polycaprolactone-poly(ethylene-glycol)block copolymer. IV: Biodegradation behavior in vitro and in vivo. Polym Adv Technol 8 11 (1997) 693-696
24. Xiong X.B., Mahmud A., Uludag H., and Lavasanifar A. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(ε-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules 8 (2007) 874-884
25. Prabu P., Dharmaraj N., Aryal Santosh., Lee B.M., Ramesh Vijaya., and Kim H.Y. Preparation and drug release activity of scaffolds containing collagen and poly(caprolactone). J Biomed Mater Res 79A (2006) 153-158
26. Wang F., Bronich T.K., Kabanov A.V., Rauh R.D., and Roovers J. Synthesis and evaluation of a star amphiphilic block copolymer from poly(ε-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjugate Chem 16 (2005) 397-405
27. Li Y.Y., Zhang X.Z., Cheng H., Zhu J.L., Cheng S.X., and Zhuo R.X. Self-assembled, thermosensitive PCL-g-P(NIPAAm-co-HEMA) micelles for drug delivery. Macromol Rapid Commun 27 (2006) 1913-1919
28. Vaz C.M., Tuijl S., Bouten C.V.C., and Baaijens F.P.T. Design of scaffolds for blood vessel tissue engineering using a multi-layering electrospinning technique. Acta Biomater 1 (2005) 575-582
29. Chung T.W., Yang M.G., Liu D.Z., Chen W.P., Pan C.I., and Wang S.S. Enhancing growth human endothelial cells on Arg-Gly-Asp (RGD) embedded poly (ε-caprolactone) (PCL) surface with nanometer scale of surface disturbance. J Biomed Mater Res 72A (2005) 213-219
30. Chong E.J., Phan T.T., Lim I.J., Zhang Y.Z., Bay B.H., Ramakrishna S., et al. Evaluation of electrospun PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution. Acta Biomater 3 (2007) 321-330
31. Li W.J., Cooper Jr. J.A., Mauck R.L., and Tuan R.S. Fabrication and characterization of six electrospun poly(α-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater 2 (2006) 377-385
32. Oh S.H., Park I.K., Kim J.M., and Lee J.H. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 28 (2007) 1664-1671
33. Kricheldorf H.R., Stricker A., and Langanke D. Tin carboxylates as initiators of ε-caprolactone. Macromol Chem Phys 202 (2001) 2963-2970
34. Storey R.F., and Sherman J.W. Kinetics and mechanism of the stannous octoate-catalyzed bulk polymerization of ε-caprolactone. Macromolecules 35 (2002) 1504-1512
35. Shuai X., Merdan T., Unger F., Wittmar M., and Kissel T. Novel biodegradable ternary copolymers hy-PEI-g-PCL-b-PEG: synthesis, characterization, and potential as efficient nonviral gene delivery vectors. Macromolecules 36 (2003) 5751-5759
36. Sanda F., Sanada H., Shibasaki Y., and Endo T. Star polymer synthesis from ε-caprolactone utilizing polyol/protonic acid initiator. Macromolecules 35 (2002) 680-683
37. Giacomelli C., and Borsali R. Macromol. ATRP of silylated glycerol monomethacrylate in organic medium for convenient synthesis of amphiphilic copolymers. Macromol Rapid Commun 29 (2008) 573-579
38. Liu J., and Liu L. Ring-opening polymerization of ε-caprolactone initiated by natural amino acids. Macromolecules 37 (2004) 2674-2676
39. Kowalski A., Libiszowski J., Biela T., Cypryk M., Duda A., and Penczek S. Kinetics and mechanism of cyclic esters polymerization initiated with Tin(II) octoate. Polymerization of ε-caprolactone and l, l-lactide co-initiated with primary amines. Macromolecules 38 (2005) 8170-8176
40. Cai Q., Zhao Y., Bei J., Xi F., and Wang S. Synthesis and properties of star-shaped polylactide attached to poly(amidoamine) dendrimer. Biomacromolecules 4 (2003) 828-834
41. Dubois P., Krishnan M., and Narayan R. Aliphatic polyester-grafted starch-like polysaccharides by ring-opening polymerization. Polymer 40 (1999) 3091-3100
42. Ydens I., Rutot D., Degée P., Six J.L., Dellacherie E., and Dubois P. Controlled synthesis of poly(ε-caprolactone)-grafted dextran copolymers as potential environmentally friendly surfactants. Macromolecules 33 (2000) 6713-6721
43. Nouvel C., Dubois P., Dellacherie E., and Six J.L. Controlled synthesis of amphiphilic biodegradable polylactide-grafted dextran copolymers. J Polym Sci A Polym Chem 42 (2004) 2577-2588
44. Lee C.T., Huang C.P., and Lee Y.D. Preparation of amphiphilic poly(l-lactide)-graft-chondroitin sulfate copolymer self-aggregates and its aggregation behavior. Biomacromolecules 7 (2006) 1179-1186
45. Liu L., Chen L., and Fang Y. Self-catalysis of phthaloylchitosan for graft copolymerization of ε-caprolactone with chitosan. Macromol Rapid Commun 27 (2006) 1988-1994
46. Jayakumar R., and Tamura H. Synthesis, characterization and thermal properties of chitin-g-poly(ε-caprolactone) copolymers by using chitin gel. Int J Biol Macromol 43 (2008) 32-36
47. Zhao Y.L., Cai Q., Jiang J., Shuai X.T., Bei J.Z., Chen C.F., et al. Synthesis and thermal properties of novel star-shaped poly(l-lactide)s with starburst PAMAM-OH dendrimer macroinitiator. Polymer 43 (2002) 5819-5825